Results 171 to 180 of about 2,739 (201)

U.S. Drug Agency Approves Vaginal Sponge

International Family Planning Perspectives, 1983
On April 1 1983 the U.S. Food and Drug Administration (FDA) approved a disposable vaginal sponge as a nonprescription contraceptive. The sponge--a new method of delivering spermicide--offers women who wish to use nonprescription contraceptives two improvements over products already on the market. It may be worn for up to 24 hours and it may be used for
Denise Kafka, Rachel Benson Gold
openaire   +1 more source

The Vaginal Contraceptive Sponge

The Nurse Practitioner, 1984
The Today vaginal contraceptive sponge is a non-prescription barrier contraceptive which, after rigorous testing, was recently approved by the Food and Drug Administration (FDA) and marketed nationally. It is a cup-shaped white polyurethane sponge six cm in diameter and 1.5 cm thick, with a removal loop.
openaire   +2 more sources

[Benzalkonium chloride for vaginal contraception--the vaginal sponge].

Geburtshilfe und Frauenheilkunde, 1990
From March 1986 to December 1987, a vaginal contraceptive, not yet commercially available in Germany, was studied in 56 women. The substance benzalconium chloride (BZC) was contained in vaginal sponges (n = 46), pessaries (n = 4) and cream (n = 6) at a dose rate of 1.18%.
U, Meyer, I, Gerhard, B, Runnebaum
openaire   +1 more source

A study of the vaginal contraceptive sponge used with and without the fertility awareness method

Contraception, 1989
The actual effectiveness rates of natural and barrier methods of family planning are lower than the theoretical ones. If couples accurately defined the limits of the fertile phase and used barriers at that time, then actual effectiveness might increase.
B, Kass-Annese, K I, Kennedy, K, Forrest, H, Danzer, A, Reading, H, Hughes   +5 more
openaire   +2 more sources

Perceived contraceptive attributes of current and former users of the vaginal sponge

Journal of Sex Research, 1992
This study investigated the relationship between perceived attributes of the contraceptive sponge and use of this innovative method. Data were collected from a national sample of 779 women: 372 current sponge users and 407 former sponge users. Current users at initial interview also participated in a six‐month follow‐up interview.
Linda J. Beckman, S. Marie Harvey, Joan Murray   +2 more
openaire   +1 more source

Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy

Journal of Drug Delivery Science and Technology, 2018
Abstract This work aimed to develop an antifungal vaginal sponge loaded with butoconazole nitrate (BN). Sponges were prepared by lyophilization of different polymers (chitosan, gelatin, hydroxyl propyl methylcellulose (HPMC) and carbopol 934) with calcium chloride as crosslinking agent, sodium carboxymethylcellulose as viscosity modifier and ...
Dalia S. Shaker, Soha Ismail, Selwan Hamed, Eman M. El-Shishtawy   +3 more
openaire   +1 more source

Collagen sponge as vaginal contraceptive barrier: Critical summary of seven years of research

American Journal of Obstetrics and Gynecology, 1985
Extensive testing of collagen sponge as a vaginal contraceptive (mechanical and chemical) showed that the original expectations regarding the safety, convenience, and efficacy were not met. The collagen sponge was tested both as a cylinder and as a diaphragm and used as such or impregnated with spermicidal detergent or with zinc salt.
M, Chvapil, W, Droegemueller, M W, Heine, J C, MacGregor, D, Dotters   +4 more
openaire   +2 more sources

Polyurethane contraceptive vaginal sponge: Product modifications resulting from user experience

Contraception, 1981
A preliminary study of a new contraceptive vaginal sponge containing the spermicide nonoxynol -9 (N-9), was undertaken to assess acceptability of the method among a group of sexually active volunteers in Mexico City. Numerous modifications of the product and its packaging resulted from user experience and feedback to the physicians and bioengineers ...
R, Aznar, G, Zamora, M, Lozano, C, Levi
openaire   +2 more sources

Recurrent bacterial vaginosis: association with vaginal sponge use.

Family practice research journal, 1992
A hypothesis-generation study was conducted to examine risk factors for bacterial vaginosis recurrences among women participating in a randomized controlled trial of male sexual partner treatment. Of the 140 women enrolled in the trial, 72 had a normal vaginal gram-stained slide at the first follow-up visit and were included in this analysis.
M B, Mengel, A B, Davis
openaire   +1 more source

Contraceptive vaginal sponge

Reactions, 1985
openaire   +1 more source